The Catalyst Issue 23 | December 2015 | Page 4

CHANGING CANCER CARE IN CENTRAL TEXAS. the number of cancer diagnoses in Texas increases, fueled by a rapidly growing and aging population, it is now more essential than ever for Baylor Scott & White Health to meet our patients where they live. Bringing comprehensive, integrated cancer care expertise to the communities we serve will ease patients’ overall anxiety in coping with this difficult disease and ultimately improve their clinical outcomes and quality of life. As Our model of cancer care doesn’t just treat the disease; it enables our patients to continue to live as normally as possible. An unprecedented step Baylor Scott & White is making a commitment to Central Texas patients, young and old, to expand cancer care services and provide a seamless patient experience from diagnosis through survivorship. Patients throughout Central Texas will have easier access to our accredited model of comprehensive cancer care, with standardized services including our nationally recognized programs in medical and radiation oncology, all under one roof and close to their homes. This model, already in place at locations in Temple, Waco, and Killeen, lessens the burden on patients and their 4 THE CATALYST December 15 | sw.org families by limiting the need to travel great distances or toggle between different healthcare systems for highquality, lifesaving treatment. “Our goal is to standardize the patient experience, to offer seamless access to the highest quality cancer treatment available whether a patient enters our doors in Temple, College Station, Waco, Marble Falls, or any of our sites in between,” says Michael Davis, director of the Scott & White Cancer Institute. All this is connected through one medical record, which enables providers in multiple specialties to work together for the patient, regardless of time or location. The strength of the Baylor Scott & White system means patients not only have access to the highest-quality treatment and survivorship programs, but also may participate in a wide array of research protocols and clinical trials, many conducted through the )Q